Alamar Biosciences (NASDAQ: ALMR) owner sells $10.25 million stake

What happened

On 2026-10-23, Qiming Corporate GP VI, Ltd. reported selling 342,626 shares of Alamar Biosciences, Inc. (NASDAQ: ALMR). The sales took place on 2026-10-21 and 2026-10-22 in multiple transactions. The reported prices ranged from $29.00 to $30.81 per share, and the filing puts the total value at about $10.25 million.

After the sale, Qiming Corporate GP VI, Ltd. held 1,789,183 shares. Form 4 identifies Qiming Corporate GP VI, Ltd. as a 10% owner of Alamar Biosciences. The filing also shows the sales were reported as several weighted-average prices, not one trade. That range matches the footnotes' weighted-average prices, which summarize multiple executions within the stated bands.

Key numbers

Metric	Latest	Change	Source
Shares sold	342,626 shares		SEC Form 4
Sale price range	$29.00 to $30.81 per share		SEC Form 4
Total sale value	about $10.25 million		SEC Form 4
Shares held after sale	1,789,183 shares		SEC Form 4
Sale as share of prior holding	16.1%		Calculated from SEC Form 4

Read more: Alamar Biosciences (ALMR) stock analysis and investment case

Why it matters

OptimistFi's case is that Alamar Biosciences is a high-uncertainty lab-instrument platform story whose value depends on proving customer adoption and financing that proof without punitive dilution. This Form 4 weakens that lens because the 342,626 shares sold were about 16.1% of the holding before the trade. The move matters because the holder remains a 10% owner.

Even so, Qiming still held 1,789,183 shares afterward, so the filing shows a reduction rather than an exit. The 16.1% figure is OptimistFi's calculation from the reported sale and the prior position. The reported price band from $29.00 to $30.81 per share shows the block cleared across two trading days. Investors can carry the retained stake into the next quarterly report as the main comparison point.

Stock perps: every US stock that trades as a perpetual future, by leverage, live

What's next

Alamar Biosciences' next quarterly report is the next scheduled check on whether this ownership pattern continues. If the stake is steadier there, the sale reads more like a one-off trim. If the stake falls again, the weak read from this filing gets stronger. A clean hold would keep the sale in the category of a partial trim. That is the cleanest comparison point for investors when the report arrives. That comparison will matter.

More from OptimistFi

• ALMR stock: the Alamar Biosciences thesis, its status and the next test to watch
• Stock research on every company OptimistFi covers

From OptimistFi Perps